Exchange: NYSE·Updated 09:18 AM EST

LLY News

News
all
press releases
Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue
Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher RevenuePR NewswireNEW YORK, Nov. 4, 2026 NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Market Updates News Commentary- U.S. stock index...
PR Newswire
Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue
Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher RevenuePR NewswireNEW YORK, Nov. 4, 2026 NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Market Updates News Commentary- U.S. stock index...
PR Newswire
More News
Novo CEO Brushes Off Post-Midterm Drug-Pricing Fears, Says ‘Our World’ Won’t Change Dramatically – NVO Stock Gains Pre-Market
CEO Mike Doustdar told CNBC that while the company has experienced weak growth in the past due to pricing, volumes have grown ‘phenomenally.’
Stocktwits
The Zacks Analyst Blog Highlights Lilly, Cisco, KLA, Oil-Dri Corp. of America and NVE
Lilly, Cisco and KLA lead five featured analyst reports, highlighting growth drivers ranging from GLP-1 demand and AI infrastructure to semiconductor advances.
Zacks
SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets
ASH will release regular meeting abstracts on Wednesday, followed by late-breaking abstracts on Dec.7.
Stocktwits
Top Analyst Reports for Eli Lilly, Cisco & KLA
Eli Lilly, Cisco and KLA lead today's featured research reports, with strong demand, AI-driven growth and expanding product opportunities supporting their prospects.
Zacks
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
Growing Demand for Next-Generation Therapies Is Putting Peptide Innovation at the Center of Healthcare’s Biggest Growth Markets   New York, NY –November 3, 2026 – Peptide-based treatments are attracting growing attention from major pharmaceutical companies as researchers push into new ways to treat diabetes, obesity, cancer, metabolic disorders and other serious diseases. The opportunity is […] The post Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion appeared first on Financial News Media.
Financial News Media
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks
LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?
Lilly's stock rose 9.6% after strong Q3 results. Can its obesity pipeline and expanding drug portfolio sustain growth amid rising competition & pricing pressure?
Zacks
Eli Lilly Stock: Is It Still a Buy at $1,400?
Key PointsThe company reported 39% revenue growth last quarter and also raised its guidance for the full year...
Nasdaq News: Markets
Novo Before Q3 Earnings: How Should Investors Play the Stock?
NVO faces intensifying GLP-1 competition, earnings cuts and pricing pressure, challenging its growth outlook ahead of Q3 results.
Zacks

Advertisement|Remove ads.